Month: July 2021

On 13th of July, 2021, the Extraordinary General Meeting of the Shareholders of AS Ekspress Grupp was held in Tallinn, Parda 6.   Pursuant to § 303 (1) of the Commercial Code, neither Hans Luik nor the companies under his control could not vote in the Extraordinary General Meeting and these votes were not taken into account in determining the representation. Out of 11 732 249 votes with voting rights 7 090 535 votes were represented at the Meeting (60.44%).  The General Meeting of the Shareholders of AS Ekspress Grupp adopted the following resolutions. 1. Decide on conclusion of a transaction with the member of the Supervisory Board and determine the terms and conditions of the transaction 1.1.       Give the Management Board of Ekspress Grupp its assent and authorise the Management Board of Ekspress Grupp to conclude a share sales agreement...

13 July 2021 Acron Group’s Commercial Output Up 6% in H1 2021   Group’s Consolidated Output (including operating results for Acron, Dorogobuzh and North-Western Phosphorous Company)Product, ‘000 t 6M 2021 6M 2020 YOY, %MINERAL FERTILISERSAmmonia 1,415 1,374 3.0Incl. in-house consumption 1,377 1,306  Nitrogen fertilisers, including 2,424 2,442 -0.7Incl. in-house consumption 427 403  AN 1,118 1,227 -8.8Incl. in-house consumption 142 135  Urea 651 568 14.7Incl. in-house consumption 284 269  Including prilled urea 163 276 -40.9Incl. in-house consumption 11 8  Including granulated urea 231 34 up by factor 6.8Incl. in-house consumption 16 3  UAN 655 648 1.1Complex fertilisers, including 1,296 1,140 13.6Incl. in-house consumption 25 16  NPK 1,201 1,080 11.2Incl. in-house consumption 25 16  Bulk...

Jordi Cruz QuoteA quote from Jordi Cruz, the director of the MPS Lisosomales.MADRID, Spain, July 13, 2021 (GLOBE NEWSWIRE) — Ultragenyx Pharmaceutical Inc., a biopharmaceutical company focused on the development and commercialization of novel therapies for serious rare and ultra-rare genetic diseases, today announced that Mepsevii® (vestronidase alfa) has been approved for reimbursement by the Sistema Nacional de Salud (SNS) for the treatment of pediatric and adult patients with Mucopolysaccharidosis VII (MPS VII; Sly syndrome) for patients of all ages. MPS VII is a progressive, rare, genetic disorder that effects an estimated 200 people in the developed world. People with MPS VII do not produce enough beta-glucuronidase, an enzyme that plays a key part in the breakdown of specific sugars in the body. The lack...

Panevezio statybos trestas AB has brought an action before the Panevezys Regional Court in respect with the decision by the state enterprise Ignalina Nuclear Power Plant to reject the bid by Panevezio statybos trestas AB in the public procurement arranged by means of an international tender for Procurement of Works for Construction of INPP Near Surface Repository for Low and Intermediate-Level Short-Lived Radioactive Waste (Construction Stages I/A, II/A) and Design, Construction and Connection of External Rainwater Drainage Networks to INPP Infrastructure. More information:Managing DirectorEgidijus UrbonasTel.: (+370 45) 505 503

FORM 8.5 (EPT/RI)   PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY   1.        KEY INFORMATION  (a)        Name of exempt principal trader:Investec Bank plc(b)        Name of offeror/offeree in relation to whose relevant securities this form relates:         Use a separate form for each offeror/offereeGood Energy Group plc(c)        Name of the party to the offer with which exempt principal trader is connected:Investec is Joint advisor to Good Energy Group plcd)        Date dealing undertaken:12th July 2021(e)        Has the EPT previously disclosed, or is it today disclosing, in respect of any other party to this offer? No  2.        DEALINGS BY THE EXEMPT PRINCIPAL TRADER   (a)        Purchases and sales  Class...

Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and the Article 223-16 of the Règlement général de l’Autorité des marchés financiers (Regulation of the French stock market authority)         Company name of the issuer:                  Renault SA13/15 quai Alphonse Le Gallo92100 Boulogne-Billancourt(ISIN code FR0000131906 – RNO)Date   Total number of issued shares     Total number of voting rights  June 30, 2021       295,722,284         Theoretical total number of voting rights(1): 398,841,057  Exercisable number of voting rights(2): 305,541,307(1) Number calculated on the basis of all shares to which voting rights are attached, including shares for which voting rights cannot be exercised, according to Article...

HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., July 13, 2021 (GLOBE NEWSWIRE) — HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM: HCM; HKEX: 13) announces the first commercial sale in China of ORPATHYS® (savolitinib), HUTCHMED’s oral, potent, and highly selective small molecule inhibitor of MET, a receptor tyrosine kinase, which occurred on July 12, 2021. This follows less than three weeks after the June 22, 2021 approval of ORPATHYS® in China for the treatment of patients with locally advanced or metastatic non-small cell lung cancer (“NSCLC”) with MET exon 14 skipping alterations who have progressed following prior systemic therapy or are unable to receive chemotherapy. Under the terms of the license and collaboration agreement between HUTCHMED and AstraZeneca (“AstraZeneca”) (LSE/STO/Nasdaq: AZN), a US$25 million non-creditable...

                                                                Paris, 13 July 2021 BELIEVE: Implementation of a Liquidity Contract with NATIXIS ODDO BHF    BELIEVE (ISIN code: FR0014003FE9), one of the world’s leading digital music companies, announces having appointed NATIXIS and ODDO BHF SCA to implement a liquidity contract, starting on July, 13 2021, for a period of one year tacitly renewable. This contract complies with the decision of the Autorité des marchés financiers (AMF) n°2021-01 of June, 22 2021 related to the establishing of liquidity contracts on shares as accepted market practice and the standard contract of the Association française des marchés financiers (AMAFI). This contract with NATIXIS ODDO BHF aims at improving Company’s shares trading on the regulated market of Euronext Paris The following resources have been allocated...